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ospital, Mahidol University
. Narkbunnam ∗, V. Boon-yasidhi, J. Tarugsa, Y. Durier,
. Khanakool, O. Witawatmongkol, B. Manaboriboon, K.
hokephaibulkit
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok,
hailand
Background: Perinatal HIV-infected children survive and live
lose to normal life from the effect of highly active antiretroviral
herapy (HAART). The information of these grown-up children and
dolescents in Thailand has been limited. Objectives: To describe
he demographic, HIV-related health status, and social charac-
eristics of perinatal HIV-infected adolescents at Siriraj Hospital,
ahidol University.
Methods: This is a cross-sectional descriptive analysis of demo-
raphic, CD4,HIV-RNA, antiretroviral therapy (ART), education, and
iving status of adolescents, ages 12-18 years old who were follow-
p at Siriraj hospital. Data were collected from medical record in
anuary 2010.
Results: Of the 81 adolescents, mean age 14.7 years, 41 (50.6%)
ere female. Fifty four (66.7%) were living with biological father
nd/or mother, 22 (27.2%) living with relatives, and 5 (6.2%) liv-
ng in foster families. Ninety-eight percent were attending regular
chool, while 2.5% had left school. By self report, 32 (39.5%)
ere sexually active. Of the 81 adolescents with medical infor-
ation available, 69 (85.2%) had HIV RNA<40 copies/mL, and 78
96.3%) had CD4>200 cells/mm3. Forty-one (50.6%)were receiving
rotease inhibitor-based regimens, 38 (46.9%) receiving non nucle-
side reverse transcriptase inhibitor-based regimens, and 2 (2.5%)
eceiving lamivudine monotherapy holding regimen, mostly from
oor adherence.
Conclusion: Perinatal HIV-infected adolescents in Bangkok
ere ingood immunologic statusbut aquarterhadvirologic failure.
ocial and education supports should be included in comprehen-
ive care to improve the outcomes.
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Hepatotoxicity of antiretrovirals in patients with human
immunodeﬁciency virus and viral hepatitis coinfections
P. Parenti ∗, L. Marconi, S. Lupo
CAICI, Rosario, Santa Fe, Argentina
Background: Antiretroviral drugs used to treat HIV may cause
hepatotoxicity. The high prevalence of persons with chronic hep-
atitis B or C coinfected, raised aminotransferses have many causes
andneither speciﬁcmarkers is a indicator of liver injury, difﬁculties
in interpreting the hepatotoxicity. Objective: We evaluated hepa-
totoxicity in HIV/HVC and/or HBV coinfected patients, risk factors
and severity.
Methods: Prospective study of HIV-1 patients with start HAART
in Hospital Provincial del Centenario from Rosario, Argentina.
Patients were classiﬁed into two groups, VHC and/or HVB coin-
fected vs. no coinfected. The major endpoint was hepatotoxicity
deﬁned as Benichou’s Score within de ﬁrst 6 months. This score is
among the few validated, but little used in clinical practice. Sec-
ondary endpoints were risk factors and severity of hepatotoxicity.
Results: 140 patients were included, 39% coinfected and 61%
no coinfected. Female were similary in both groups 21% and 27%
respectively. Thehepatotoxicitywithin theﬁrst 6monthwas44.3%,
75% in coinfected patients and 25% in no coinfected. RR 3.97 (IC95%
conﬁdence interval 2.34-6.75, p <0.0001). The hepatotoxicity was
associated with the use of illicit drugs and alcohol, symptoms, high
level aminotransferases previous to HAART and NNRTI +PI. 3% of
hepatotoxicity was severe.
Conclusion: 44% of HIV patients experienced hepatotoxicity,
75% in coinfected vs 25% in no coinfected. The relative risk of hep-
atoxocity was almost 4 times higher among in chronic hepatitis
coinfected patients, comparedwith thosewithHIV non-coinfected.
In multivariate analysis, the risk factors were illicit drugs, alco-
hol, symptoms, high level aminotransferases andNRTI + PI. Only 3%
of hepatotoxicity was severe. The Benichou’s Score is better than
level of aminotransferase for evaluated hepatotoxicity, so it would
recommended for use in clinical practice.
http://dx.doi.org/10.1016/j.ijid.2012.05.754
